• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SUREFLEX FIBERS; POWERED LASER SURGICAL INSTRUMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SUREFLEX FIBERS; POWERED LASER SURGICAL INSTRUMENT Back to Search Results
Model Number S-LLF200TG
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code Tissue Damage (2104)
Date of Event 09/10/2020
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that during a ureteroscopy procedure, the physician was holding the fiber with two fingers, when the fiber ruptured causing a hand wound.The procedure was completed with a second fiber.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUREFLEX FIBERS
Common Device Name
POWERED LASER SURGICAL INSTRUMENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
150 baytech drive
san jose CA 95134
MDR Report Key10652750
Report Number2937094-2020-00854
Device Sequence Number14353722
Product Code GEX
UDI-Device Identifier00878953004822
UDI-Public00878953004822
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K140679
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 10/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/18/2021
Device Model NumberS-LLF200TG
Device Catalogue NumberS-LLF200TG
Device Lot Number0022812964
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 09/28/2020
Initial Report FDA Received Date10/08/2020
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-